Tissue Distribution, Pharmacokinetics, Safety, and Tolerability After a Single Dose of TNP-2092 in Participants Undergoing Primary Total Hip or Knee Arthroplasty
Clinical trial NCT04294862 · COMPLETED
Trial details
- NCT number
- NCT04294862
- Sponsor
- TenNor Therapeutics Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-01
- Primary completion
- 2021-12-31
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.